Global Cyclin Dependent Kinase 6 Market Status and Outlook 2018-2025

August 2018 | 147 pages | ID: GC36990B89EEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Beta Pharma Inc
• Eli Lilly and Company
• FLX Bio Inc
• G1 Therapeutics Inc
• Jiangsu Hengrui Medicine Co Ltd
• Novartis AG
• Onconova Therapeutics Inc
• Pfizer Inc
• Teijin Pharma Ltd
• ViroStatics srl
• XuanZhu Pharma Co Ltd

Market by Type

• ON-123300
• FLX-925
• G-1T100182
• BPI-1178
• Others

Market by Application

• Ependymoma
• Head and Neck Cancer
• Melanoma
• Neuroblastoma
• Prostate Cancer
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Cyclin Dependent Kinase 6 Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 ON-123300
  3.1.2 FLX-925
  3.1.3 G-1T100182
  3.1.4 BPI-1178
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Ependymoma
  4.1.2 Head and Neck Cancer
  4.1.3 Melanoma
  4.1.4 Neuroblastoma
  4.1.5 Prostate Cancer
  4.1.6 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 ON-123300 Production by Region
    6.1.1.2 FLX-925 Production by Region
    6.1.1.3 G-1T100182 Production by Region
    6.1.1.4 BPI-1178 Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Ependymoma Production by Region
    6.1.2.2 Head and Neck Cancer Production by Region
    6.1.2.3 Melanoma Production by Region
    6.1.2.4 Neuroblastoma Production by Region
    6.1.2.5 Prostate Cancer Production by Region
    6.1.2.6 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 ON-123300 Demand by Region
    6.2.1.2 FLX-925 Demand by Region
    6.2.1.3 G-1T100182 Demand by Region
    6.2.1.4 BPI-1178 Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Ependymoma Demand by Region
    6.2.2.2 Head and Neck Cancer Demand by Region
    6.2.2.3 Melanoma Demand by Region
    6.2.2.4 Neuroblastoma Demand by Region
    6.2.2.5 Prostate Cancer Demand by Region
    6.2.2.6 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Beta Pharma Inc
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Eli Lilly and Company
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 FLX Bio Inc
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 G1 Therapeutics Inc
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Jiangsu Hengrui Medicine Co Ltd
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Novartis AG
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Onconova Therapeutics Inc
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Pfizer Inc
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Teijin Pharma Ltd
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 ViroStatics srl
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 XuanZhu Pharma Co Ltd

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Cyclin Dependent Kinase 6 Industry Dynamics & Regulations List
Table Global Cyclin Dependent Kinase 6 Sales Revenue, Cost and Margin, 2015-2018E
Table Global Cyclin Dependent Kinase 6 Market Status by Type 2015-2018E, in USD Million
Table Global Cyclin Dependent Kinase 6 Market Status by Application 2015-2018E, in USD Million
Table Global Cyclin Dependent Kinase 6 Market Status by Application 2015-2018E, in Volume
Table Global Cyclin Dependent Kinase 6 Market by Region 2015-2018E, in USD Million
Table Global Cyclin Dependent Kinase 6 Market Share by Region in 2018, in USD Million
Table Global Cyclin Dependent Kinase 6 Market by Region 2015-2018E, in Volume
Table Global Cyclin Dependent Kinase 6 Market Share by Region in 2018, in Volume
Table ON-123300 Production Value by Region 2015-2018E, in USD Million
Table ON-123300 Production Volume by Region 2015-2018E, in Volume
Table FLX-925 Production Value by Region 2015-2018E, in USD Million
Table FLX-925 Production Volume by Region 2015-2018E, in Volume
Table G-1T100182 Production Value by Region 2015-2018E, in USD Million
Table G-1T100182 Production Volume by Region 2015-2018E, in Volume
Table BPI-1178 Production Value by Region 2015-2018E, in USD Million
Table BPI-1178 Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Ependymoma Production Value by Region 2015-2018E, in USD Million
Table Ependymoma Production Volume by Region 2015-2018E, in Volume
Table Head and Neck Cancer Production Value by Region 2015-2018E, in USD Million
Table Head and Neck Cancer Production Volume by Region 2015-2018E, in Volume
Table Melanoma Production Value by Region 2015-2018E, in USD Million
Table Melanoma Production Volume by Region 2015-2018E, in Volume
Table Neuroblastoma Production Value by Region 2015-2018E, in USD Million
Table Neuroblastoma Production Volume by Region 2015-2018E, in Volume
Table Prostate Cancer Production Value by Region 2015-2018E, in USD Million
Table Prostate Cancer Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table ON-123300 Market Size by Region 2015-2018E, in USD Million
Table ON-123300 Market Size by Region 2015-2018E, in Volume
Table FLX-925 Market Size by Region 2015-2018E, in USD Million
Table FLX-925 Market Size by Region 2015-2018E, in Volume
Table G-1T100182 Market Size by Region 2015-2018E, in USD Million
Table G-1T100182 Market Size by Region 2015-2018E, in Volume
Table BPI-1178 Market Size by Region 2015-2018E, in USD Million
Table BPI-1178 Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Ependymoma Market Size by Region 2015-2018E, in USD Million
Table Ependymoma Market Size by Region 2015-2018E, in Volume
Table Head and Neck Cancer Market Size by Region 2015-2018E, in USD Million
Table Head and Neck Cancer Market Size by Region 2015-2018E, in Volume
Table Melanoma Market Size by Region 2015-2018E, in USD Million
Table Melanoma Market Size by Region 2015-2018E, in Volume
Table Neuroblastoma Market Size by Region 2015-2018E, in USD Million
Table Neuroblastoma Market Size by Region 2015-2018E, in Volume
Table Prostate Cancer Market Size by Region 2015-2018E, in USD Million
Table Prostate Cancer Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalCyclin Dependent Kinase 6 Forecast by Type 2019F-2025F, in USD Million
Table Cyclin Dependent Kinase 6 Forecast by Type 2019F-2025F, in Volume
Table Cyclin Dependent Kinase 6 Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Cyclin Dependent Kinase 6 Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Cyclin Dependent Kinase 6 Market Forecast by Region 2019F-2025F, in USD Million
Table Cyclin Dependent Kinase 6 Market Forecast by Region 2019F-2025F, in Volume
Table Beta Pharma Inc Information
Table Cyclin Dependent Kinase 6 Sales, Cost, Margin of Beta Pharma Inc
Table Eli Lilly and Company Information
Table Cyclin Dependent Kinase 6 Sales, Cost, Margin of Eli Lilly and Company
Table FLX Bio Inc Information
Table Cyclin Dependent Kinase 6 Sales, Cost, Margin of FLX Bio Inc
Table G1 Therapeutics Inc Information
Table Cyclin Dependent Kinase 6 Sales, Cost, Margin of G1 Therapeutics Inc
Table Jiangsu Hengrui Medicine Co Ltd Information
Table Cyclin Dependent Kinase 6 Sales, Cost, Margin of Jiangsu Hengrui Medicine Co Ltd
Table Novartis AG Information
Table Cyclin Dependent Kinase 6 Sales, Cost, Margin of Novartis AG
Table Onconova Therapeutics Inc Information
Table Cyclin Dependent Kinase 6 Sales, Cost, Margin of Onconova Therapeutics Inc
Table Pfizer Inc Information
Table Cyclin Dependent Kinase 6 Sales, Cost, Margin of Pfizer Inc
Table Teijin Pharma Ltd Information
Table Cyclin Dependent Kinase 6 Sales, Cost, Margin of Teijin Pharma Ltd
Table ViroStatics srl Information
Table Cyclin Dependent Kinase 6 Sales, Cost, Margin of ViroStatics srl
Table XuanZhu Pharma Co Ltd Information
Table Cyclin Dependent Kinase 6 Sales, Cost, Margin of XuanZhu Pharma Co Ltd
Table Global Cyclin Dependent Kinase 6 Sales Revenue by Company 2015-2017, in USD Million
Table Global Cyclin Dependent Kinase 6 Sales Volume by Company 2015-2017, in Volume
Table Global Cyclin Dependent Kinase 6 Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Cyclin Dependent Kinase 6 Picture
Figure Cyclin Dependent Kinase 6 Industry Chain Diagram
Figure Global Cyclin Dependent Kinase 6 Sales Revenue 2015-2018E, in USD Million
Figure Global Cyclin Dependent Kinase 6 Sales Volume 2015-2018E, in Volume
Figure Global Cyclin Dependent Kinase 6 Market Status by Type 2015-2018E, in Volume
Figure North America Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in USD Million
Figure North America Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in Volume
Figure Europe Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in USD Million
Figure Europe Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in Volume
Figure South America Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in USD Million
Figure South America Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in Volume
Figure Middle East Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in Volume
Figure Africa Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in USD Million
Figure Africa Cyclin Dependent Kinase 6 Market Size and Growth 2015-2018E, in Volume
Figure Global Cyclin Dependent Kinase 6 Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Cyclin Dependent Kinase 6 Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Cyclin Dependent Kinase 6 Sales Price Forecast 2019F-2025F
Figure Global Cyclin Dependent Kinase 6 Gross Margin Forecast 2019F-2025F
Figure Global Cyclin Dependent Kinase 6 Sales Revenue by Company in 2018, in USD Million
Figure Global Cyclin Dependent Kinase 6 Price by Company in 2018
Figure Global Cyclin Dependent Kinase 6 Gross Margin by Company in 2018